| Active substance | Human Growth Hormone |
|---|---|
| Storage conditions | Store at controlled room temperature, protect from light |
| Side effects | Local injection site reactions, altered testosterone levels, potential bone density reduction |
| Effects | Induces a temporary decrease in gonadotropin secretion |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically, 2.1 mg implant every 6 months |
| Half-life | 2-3 hours |
| Main action | Increases the production of gonadotropins |
| Substance class | Gonadotropin-releasing hormone agonist (GnRH agonist) |
| Formula | C64H83N17O12В·C2H4O2 |
| Chemical name | Deslorelin acetate |
| Trade name | Suprelorin, Ovuplant |
| Blood pressure | No significant effects |
| WAREHOUSE | International Warehouse 3 |
| Also known as | GnRH agonist implant |
| Lab Test | Hormone levels (LH, FSH) |
| Aromatization | No |
| Hepatotoxicity | No |
| HBR | No |
| Water Retention | No |
| Acne | No |
| Use in sports | Not typically used or recommended in sports |
| Manufacturer | Beligas |
Reviews
There are no reviews yet.